Author Archives: Syndicated Content
WHO defends data after concluding Gilead’s remdesivir flopped COVID trial
ZURICH/GENEVA (Reuters) - A World Health Organization (WHO) trial that concluded Gilead Sciences Inc.'s remdesivir did not significantly help COVID-19 patients is reliable, a scientist who evaluated t...
Oct 16, 2020
Wall Street futures perk up on vaccine hopes as stimulus stand-off weighs
By Medha Singh (Reuters) - U.S. stock index futures rose on Friday as Pfizer said it could apply for emergency use of its COVID-19 vaccine candidate as early as November, shaking off worries over a st...
Oct 16, 2020
China supports G20 proposal to extend debt relief to poor countries: PBOC head
BEIJING (Reuters) - China supports a G20 proposal to further extend debt relief to poor countries, the head of its central bank, Yi Gang, told a G20 videoconference on Thursday, according to a stateme...
Oct 16, 2020
Empty Wimbledon part of organisers’ 2021 plans
LONDON (Reuters) - Next year's Wimbledon Championships could be held without spectators amid the COVID-19 pandemic, the organisers of the grasscourt Grand Slam said on Friday. The tournament in Englan...
Oct 16, 2020
Malaysia reports 629 new coronavirus cases, 6 new deaths
KUALA LUMPUR (Reuters) - Malaysia reported 629 new coronavirus cases on Friday, raising its cumulative tally of infections to 18,758, the health ministry said. The Southeast Asian country, which has i...
Oct 16, 2020
Swiss COVID-19 infections hit another record
ZURICH/GENEVA (Reuters) - Switzerland reported another daily record of 3,105 new coronavirus cases on Friday as a second wave of infection gripped the country. The public health agency reported a tota...
Oct 16, 2020
Investors keep wary eye on Thai protests as stock market slips
By Scott Murdoch and Tom Westbrook HONG KONG/SINGAPORE (Reuters) - Escalating anti-government protests in Thailand could push one of this year's worst performing stock markets even lower, some investo...
Oct 16, 2020
Pfizer sees emergency use filing for COVID-19 vaccine after U.S. election
(Reuters) - Pfizer Inc expects to provide safety data and file for authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, delaying any clarity on the vac...
Oct 16, 2020
Analysis: Sales of first big COVID-19 drug, remdesivir, may disappoint
By Deena Beasley (Reuters) - Investors betting on big profits from COVID-19 treatments may get an unwelcome surprise when Gilead Sciences Inc reports quarterly results this month. Its remdesivir, the ...
Oct 16, 2020
Croatia daily COVID-19 infections exceed 1,000 for first time
ZAGREB (Reuters) - Croatia reported 1,131 COVID-19 cases on Friday, the first time the Adriatic country of four million people has exceeded 1,000 infections a day. In the last 10 days the number of ne...
Oct 16, 2020
